Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (2 ops.)
Latest filing published 28 May 2026 for HLB바이오스텝. Read the official filing
Insider track record
Disclosed buys
3
Disclosed sells
2
Signal history
No signal scores available.
Closed purchases
Market purchases
3
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -59.9%Entry ₩34,800 · Close at T+90 ₩13,950
- -60.3%Entry ₩34,800 · Close at T+90 ₩13,799
- +3.4%Entry ₩6,105 · Close 08 Oct 2026 ₩6,310
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
김명진: trading record in brief
김명진, listed as senior executive, has filed trades across 2 companies (mainly through DART (FSS)), most often in HLB바이오스텝 and 액스비스. We count 5 filings; the first trade dates from 5 March 2026 and the latest from 21 May 2026.
Market trades split into 3 purchases and 2 sales. The amount is not disclosed for 5 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 28 May 2026 with an open-market sale in HLB바이오스텝. The latest purchase dates back some time: it was published 222 days ago, on 10 March 2026. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to 김명진
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
5 of 5 declarations
